Relatives of a Grand Haven family killed in murder-suicide want "internet sleuths" to stop, and people in Muskegon Heights respond to the federal raid at city hall last week. Also, Matt says this ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The world uses a lot of copper, but thanks to the energy transition and data centers, it’ll need a lot more. Between now and 2050, we’ll have to produce more copper than has been mined throughout all ...

LOS ANGELES, June 30, 2026 (GLOBE NEWSWIRE) — Arcturus, an advanced materials company that infuses carbon nanomaterials into metals to unlock step-change improvements in electrical, thermal, and ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. A new AI trend, loop engineering, involves instructing AI to ...

When organizers of the 1933 World’s Fair in Chicago wanted a splashy and futuristic way to kick things off on opening night, astronomer Edwin Frost of Yerkes Observatory had an idea: Turn on the ...

View source version on businesswire.com: https://www.businesswire.com/news/home/20260507780817/en/ The articles, information, and content displayed on this webpage ...

GRAND RAPIDS, Mich. (WOOD) — Grand Rapids is rolling out a pared down DASH route, with the shuttles not going as far north or south but completing a loop more quickly. The city launched the yearlong ...

The last time I spoke about Arcturus Therapeutics Holdings Inc. (ARCT) it was with a Seeking Alpha article entitled "Arcturus: LUNAR-CF For CF Presses On With 1st Half Of 2025 Interim Data." Regarding ...

In the preceding three months, 4 analysts have released ratings for Arcturus Therapeutics (NASDAQ:ARCT), presenting a wide array of perspectives from bullish to bearish. In the table below, you'll ...

The company expects to initiate the 12-week Phase II ARCT-032 study in the first half of 2026, enrolling up to 20 participants and focusing on safety and early signs of clinical benefit. For ARCT-810, ...